Feinstein Institute for Medical Research
Also known as: Adrianna Vlachos | FEINSTEIN | Feinstein Institute | Feinstein Institute for Medical Research | Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases | Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System | Feinstein Institute for Medical Research NS-LIJ Health System | Marc L Gordon, MD | THE FEINSTEIN INST | The Feinstein Institute for Medical Research | The Feinstein Institute for Medical Research NS-LIJ Health System
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2006First marketed drug
Aug 19, 2005First NDA
Aug 23, 2007Last known activity
May 16, 2022
Timeline
1990s
- Jan 1, 1991
Feinstein Institute for Medical Research— Founded
2000s
- Aug 19, 2005
fludeoxyglucose f-18— NDA Secondary Org
- Aug 23, 2007
ammonia n-13— NDA Organization
2010s
- Oct 10, 2019
fluorodopa— Marketing Organization
Drugs by trial phase (32 distinct, 25 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (26 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Adrenal Hyperplasia, Congenital
- Adrenocortical Hyperfunction
- Adrenogenital Syndrome
- Alzheimer Disease
- Anemia
- Anemia, Diamond-Blackfan
- Arthritis
- Arthritis, Rheumatoid
- Astrocytoma
- Ear Diseases
- Glioblastoma
- Huntington Disease
- Hyperplasia
- Labyrinth Diseases
- Labyrinthitis
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- Metabolic Syndrome
- Nephritis
- Neurilemmoma
- Neuroma, Acoustic
- Obesity, Abdominal
- Parkinson Disease
- Red-Cell Aplasia, Pure
- Syndrome
- Telangiectasia, Hereditary Hemorrhagic
- Telangiectasis
Marketed drugs (5)
Recent trials (34)
- NCT05201469Study chairPhase 2May 16, 2022
- NCT04486118Overall official - principal investigatorPhase 2Feb 1, 2021
- NCT04070378Lead sponsorPhase 2Oct 1, 2019
- NCT04070378Sponsor investigatorPhase 2Oct 1, 2019
- NCT03548246CollaboratorPhase 2Sep 30, 2019
- NCT03966053Lead sponsorPhase 1/Phase 2Jun 1, 2019
- NCT03966053Sponsor investigatorPhase 1/Phase 2Jun 1, 2019
- NCT03397004CollaboratorPhase 2Sep 30, 2018
- NCT03093402Study chairPhase 2Aug 1, 2017
- NCT02574910CollaboratorPhase 1Dec 1, 2016
- NCT02481674Overall official - principal investigatorPhase 2Jul 1, 2015
- NCT02260934Study chairPhase 2Oct 1, 2014
- NCT02283242CollaboratorPhase 4Mar 1, 2014
- NCT01973543CollaboratorPhase 1Oct 1, 2013
- NCT01950312CollaboratorPhase 2Aug 1, 2013
Details
- Founded
- Manhasset, NY, US Jan 1, 1991
- First NDA
- Aug 23, 2007
- Last known activity
- May 16, 2022